ASCO 2018.
Oasi ALK
Oasi ALK - ASCO2018
Contributi
Video, Slide, Cartelle Zip
ASCO 2018 – ALK – 03/06/2018
Updated efficacy and safety data from the global phase III ALEX study of alectinib (ALC) vs crizotinib (CZ) in untreated advanced ALK+ NSCLC
A cura di Filippo de Marinis
Diventa socio AIOT, entra e compila il form di registrazione.
